Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H24N6O4 |
| Molecular Weight | 340.3787 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCCCC[C@H](NC(=O)[C@H](CC1=CNC=N1)NC(=O)CN)C(O)=O
InChI
InChIKey=MVORZMQFXBLMHM-QWRGUYRKSA-N
InChI=1S/C14H24N6O4/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24)/t10-,11-/m0/s1
| Molecular Formula | C14H24N6O4 |
| Molecular Weight | 340.3787 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Prezatide is a tripeptide molecule consisiting of lysine, glycine and histidine, also known as GHK (glycyl-L-histidyl-L-lysine), that forms a complex with copper ions. Prezatide is used in cosmetic products (skin and hair) and is known help wound healing. Prezatide increases the synthesis and deposition of type I collagen and glycosaminoglycan. It is thought to play a role in the modulation of tissue remodeling by increases the expression of matrix metalloproteinase-2, as well as tissue inhibitor of matrix metalloproteinases-1 and -2. Prezatide has antioxidant activity due to its ability to supply copper for superoxide dismutase and anti-inflammatory ability due to the blockage the of iron (Fe2+) release during injury.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:35:59 GMT 2025
by
admin
on
Mon Mar 31 18:35:59 GMT 2025
|
| Record UNII |
39TG2H631E
|
| Record Status |
FAILED
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
49557-75-7
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
m5722
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | Merck Index | ||
|
379527
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
DB11296
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
39TG2H631E
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
DTXSID30197831
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
39TG2H631E
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
Copper peptide GHK-Cu
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
300000053816
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
75430
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
73587
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | |||
|
1368533
Created by
admin on Mon Mar 31 18:35:59 GMT 2025 , Edited by admin on Mon Mar 31 18:35:59 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |